ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 33 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 3,176 | -0.1% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 3,180 | -43.5% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 5,632 | +52.6% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 3,691 | +365.4% | 0.00% | – |
| Q3 2021 | $1,000 | -97.4% | 793 | -96.1% | 0.00% | – |
| Q2 2021 | $39,000 | +680.0% | 20,161 | +1074.2% | 0.00% | – |
| Q1 2021 | $5,000 | -96.1% | 1,717 | -94.7% | 0.00% | – |
| Q4 2020 | $129,000 | +1512.5% | 32,311 | +1030.5% | 0.00% | – |
| Q3 2020 | $8,000 | -96.5% | 2,858 | -96.2% | 0.00% | – |
| Q2 2020 | $227,000 | +54.4% | 74,968 | +0.3% | 0.00% | – |
| Q1 2020 | $147,000 | -88.1% | 74,740 | -55.3% | 0.00% | – |
| Q4 2019 | $1,231,000 | +268.6% | 167,371 | +126.1% | 0.00% | – |
| Q3 2019 | $334,000 | -48.5% | 74,012 | +13.7% | 0.00% | – |
| Q2 2019 | $649,000 | +1522.5% | 65,097 | +1816.9% | 0.00% | – |
| Q1 2019 | $40,000 | -90.3% | 3,396 | -90.1% | 0.00% | – |
| Q4 2018 | $413,000 | -33.1% | 34,360 | -5.1% | 0.00% | – |
| Q3 2018 | $617,000 | -21.4% | 36,222 | -21.2% | 0.00% | – |
| Q2 2018 | $785,000 | – | 45,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|